ArticleClinical journal of gastroenterology2026
Hepatic sarcoidosis presenting with portal hypertension without histologically established cirrhosis and reticular hepatic imaging features.
Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a 50-year-old man who was referred for evaluation of suspected hepatic sarcoidosis after non-caseating granulomas were incidentally identified on the liver surface during surgery. Laboratory tests showed a cholestatic pattern with elevated alkaline phosphatase and gamma-glutamyl transpeptidase, mild thrombocytopenia, and increased angiotensin-converting enzyme and soluble interleukin-2 receptor levels. Contrast-enhanced computed tomography demonstrated marked surface irregularity and reticular hypoattenuated linear structures within the liver. Gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasonography revealed non-enhancing septum-like structures, whereas the intervening hepatic parenchyma showed preserved contrast uptake in the hepatobiliary phase of magnetic resonance imaging and in the post-vascular phase of contrast-enhanced ultrasonography. Upper gastrointestinal endoscopy identified esophagogastric varices. Liver biopsy showed preserved hepatic architecture without diffuse parenchymal inflammation. Azan staining demonstrated spatially heterogeneous portal fibrosis, with marked fibrous expansion in two portal tracts and mild fibrous expansion in several other portal tracts. Neither portal-portal nor portal-central bridging fibrosis was identified, and regenerative nodules surrounded by fibrous septa were not evident. Non-caseating epithelioid granulomas containing multinucleated giant cells were observed within fibrotic portal tracts. The patient was diagnosed with hepatic and splenic sarcoidosis complicated by portal hypertension without histologically established cirrhosis. This case highlights that portal tract-predominant, spatially heterogeneous fibrosis in hepatic sarcoidosis may contribute to portal hypertension and distinctive reticular hepatic imaging findings, even in the absence of histologically established cirrhosis.
Indexed as
Identifiers
42550407What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.